The most up to date reporting and breakthroughs in anal cancer and HPV research, and Anal Cancer Foundation’s latest activities and events.
The Anal Cancer Foundation is proud to participate in ACRIA and GMHC‘s journal Achieve. Foundation board members, Camille Almada and Nicoletta Bumbac contributed The Cancer That Dare Not Speak Its Name to the Fall 2011 publication focusing on Living With HIV. Achieve brings needed prevention and treatment information to the people living with HIV, their doctors, and… read more
Today the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) approved the quadrivalent HPV vaccine for routine use in males aged 11-12. The ACIP also approved routine catch-up vaccination for males aged 13-21. The Anal Cancer Foundation applauds the ACIP’s affirmative vote to routinely recommend the quadrivalent HPV vaccine for boys…. read more
Executive Summary The 27th International Papillomavirus (IPV) Conference & Clinical Workshop took place on September 17-22, in Berlin. The Foundation attended this year’s IPV Conference to learn about the latest developments in scientific and clinical research along with public health related studies. Several studies piqued our interest; especially regarding the prevalence of HPV infection in… read more